Bayesian evidence synthesis to extrapolate survival estimates in cost-effectiveness studies

Statistics in Medicine

Volumn 25, Issue 11, 2006, Pages 1960-1975

  Demiris, Nikolaos ^a   Sharples, Linda D ^a  

^a MRC BIOSTATISTICS UNIT   (United Kingdom)

Author keywords

Bayesian survival analysis; Cost effectiveness; Evidence synthesis; Gamma process; Life years gained; Semi parametric models; Survival extrapolation

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

ARTICLE; BAYES THEOREM; CLINICAL TRIAL; COHORT ANALYSIS; COMPUTER PROGRAM; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; HEART ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; LONG TERM CARE; MATHEMATICAL COMPUTING; META ANALYSIS; METHODOLOGY; PROPORTIONAL HAZARDS MODEL; REGISTER; STATISTICS; SURVIVAL; SYSTEMATIC REVIEW; UNITED KINGDOM;

AGED; COHORT STUDIES; DEFIBRILLATORS, IMPLANTABLE; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; MODELS, ECONOMIC; PROPORTIONAL HAZARDS MODELS; SOFTWARE; SURVIVAL ANALYSIS; VENTRICULAR FIBRILLATION;

EID: 33744802899     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.2366     Document Type: Article

References (24)

1. O'Hagan A, Stevens JW. Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies. Statistical Methods in Medical Research 2002; 11:469-490.
2. Cooper NJ, Abrams KR, Sutton AJ, Turner D, Lambert PC. A Bayesian approach to Markov modelling in cost-effectiveness analyses: application to taxane use in advanced breast cancer. Journal of the Royal Statistical Society, Series A 2003; 166:389-405.
3. Ibrahim JG, Chen M-H, Sinha D. Bayesian Survival Analysis. Springer: New York, 2001.
4. Spiegelhalter DJ, Thomas A, Best NG, Lunn D. WinBUGS 1.4 User Manual. URL: http://www.mrc-bsu.cam.ac.uk/bugs/winbugs/manual14.pdf. MRC Biostatistics Unit, Cambridge, 2004.
5. Amiodarone Trials Meta-Analysis Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infraction and in congestive heart failure: meta-analysis of individual data from 6500 patients randomized trials. Lancet 1997; 350:1417-1424.
6. Conolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuhk H-K, Zipes DP, Greene HL, Boczor S, Domanski M, Follman D, Gent M, Roberts RS. On behalf of the investigators of the AVID, CASH and CIDS studies. European Heart Journal 2000; 21:2071-2078.
7. Buxton MJ, Caine N, Connelly D, Grace AA, Jackson CJ, Parkes J, Sharples LD. A review of the evidence on the effects and costs of implantable cardioverter defibrillator (ICD) therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a U.K. context. Health Technology Assessment 2005, in press.
8. Cox DR. Regression models and life tables (with discussion). Journal of the Royal Statistical Society, Series B 1972; 34:187-220.
9. Aalen OO. A linear regression model for the analysis of lifetimes. Statistics in Medicine 1989; 9:907-925.
10. Lin DY, Ying Z. Semiparametric analysis of the additive risk model. Biometrika 1994; 81:61-71.
11. Andersen PK, Gill RD. Cox's regression model for counting processes: a large sample study. Annals of Statistics 1982; 10:1100-1120.
12. Andersen PK, Borgan O, Gill RD, Keiding N. Statistical Models Based on Counting Processes. Springer: New York, 1993.
13. Doksum KA. Tailfree and neutral random probabilities and their posterior distributions. Annals of Probability 1974; 2:183-201.
14. Kalbfleisch JD. Non-parametric Bayesian analysis of survival time data. Journal of the Royal Statistical Society, Series B 1978; 40:214-221.
15. Hjort NL. Nonparametric Bayes estimators based on beta processes in models of life history data. Annals of Statistics 1990; 18:1259-1294.
16. Dykstra RL, Laud PW. A Bayesian nonparametric approach to reliability. Annals of Statistics 1981; 9:356-367.
17. Laud PW, Damien P, Walker SG. Computations via auxiliary random functions for survival models. Business Working Paper, University of Michigan, 2000.
18. Sinha D, Ibrahim JG, Chen M-H. A Bayesian justification of Cox's partial likelihood. Biometrika 2003; 90: 629-641.
19. Dellaportas P, Smith AFM. Bayesian inference for generalised linear and proportional hazards models via Gibbs sampling. Applied Statistics 1993; 42:443-459.
20. Clayton DG. A Monte Carlo method for Bayesian inference in frailty models. Biometrics 1991; 47:467-485.
21. Warn DE, Thompson SG, Spiegelhalter DJ. Bayesian random effects meta-analysis of trials with binaiy outcomes: methods for the absolute risk difference and relative risk scales. Statistics in Medicine 2002; 21:1601-1623.
22. Spiegelhalter DJ, Best NG, Carlin BP. van der Linde A. Bayesian measures of model complexity and fit (with discussion). Journal of the Royal Statistical Society, Series B 2002; 64:583-639.
23. Andersen PK, Borch-Johnsen K, Deckert T, Green A, Hougaard P, Keiding N, Kreiner S. A Cox regression model for the relative mortality and its application to diabetes mellitus survival data. Biometrics 1985; 41: 921-932.
24. Nieto-Barajas LE, Walker SG. Markov beta and gamma processes for modelling hazard rates. Scandinavian Journal of Statistics 2002; 29:413-424.